• 繁體中文
  • English
  • Home
  • Kaohsiung Medical University
  • Office of Secretariat
    • Secretary-General
    • Secretary
    • Division of Administrative Affairs
    • Division of Regulation Affairs
    • Division of Alumni & Public Affairs
    • Division of New Career Development
  • Donation Service
  • Alumni Information Service (Chinese)
  • Contact Us
  • Home
  • KMU Focus
  • Developing a Dual-Prodrug IFNx–ICB Antibody Locking Platform to Enhance the Efficacy and Safety of Immune Checkpoint Blockade Therapy

Developing a Dual-Prodrug IFNx–ICB Antibody Locking Platform to Enhance the Efficacy and Safety of Immune Checkpoint Blockade Therapy

2014 © K.M.U Office of Secretariat
Recommend using Chrome / Safari / Firefox

  • Address: 9F, International Academic Research Building, 100, Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan
  • TEL: +886-7-312-1101 ext. 2101/2102/2103
  • FAX: +886-7-321-2062
  • E-mail: sec@kmu.edu.tw

 

Go to top